CoChat

GGTase-I deficiency reduces tumor formation and improves survival in mice with K-RAS–induced lung cancer

Open access
Sjogren, Anna-Karin M., Andersson, Karin M.E., Liu, Meng, Cutts, Briony A., Karlsson, Christin, Wahlstrom, Annika M., Dalin, Martin, Weinbaum, Carolyn, Casey, Patrick J., Tarkowski, Andrej, Swolin, Birgitta, Young, Stephen G., Bergo, Martin O. · 2007 · Journal of Clinical Investigation
Cited by 117

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Abstract

Protein geranylgeranyltransferase type I (GGTase-I) is responsible for the posttranslational lipidation of CAAX proteins such as RHOA, RAC1, and cell division cycle 42 (CDC42). Inhibition of GGTase-I has been suggested as a strategy to treat cancer and a host of other diseases. Although several GGTase-I inhibitors (GGTIs) have been synthesized, they have very different properties, and the effects of GGTIs and GGTase-I deficiency are unclear. One concern is that inhibiting GGTase-I might lead to severe toxicity. In this study, we determined the effects of GGTase-I deficiency on cell viability and K-RAS-induced cancer development in mice. Inactivating the gene for the critical beta subunit of GGTase-I eliminated GGTase-I activity, disrupted the actin cytoskeleton, reduced cell migration, and blocked the proliferation of fibroblasts expressing oncogenic K-RAS. Moreover, the absence of GGTase-I activity reduced lung tumor formation, eliminated myeloproliferative phenotypes, and increased survival of mice in which expression of oncogenic K-RAS was switched on in lung cells and myeloid cells. Interestingly, several cell types remained viable in the absence of GGTase-I, and myelopoiesis appeared to function normally. These findings suggest that inhibiting GGTase-I may be a useful strategy to treat K-RAS-induced malignancies.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1172/jci30868

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Cited by

See all 117

Metadata

Authors
Sjogren, A.-K. M., Andersson, K. M. E., Liu, M., Cutts, B. A., Karlsson, C., Wahlstrom, A. M., Dalin, M., Weinbaum, C., Casey, P. J., Tarkowski, A., Swolin, B., Young, S. G., & Bergo, M. O.
Venue
Journal of Clinical Investigation
Published
2007-05-01
Volume
117
Issue
5
Pages
1294-1304
ISSN
0021-9738 (ISSN-L)
OpenAlex
W2137566722
Cited by
117
References
6
FWCI
2.99
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: GGTase-I deficiency reduces tumor formation and improves survival in mice with K-RAS–induced lung cancer. https://app.cochat.ai/papers/10.1172/jci30868
The paper
Sjogren, A.-K. M., Andersson, K. M. E., Liu, M., Cutts, B. A., Karlsson, C., Wahlstrom, A. M., Dalin, M., Weinbaum, C., Casey, P. J., Tarkowski, A., Swolin, B., Young, S. G., & Bergo, M. O. (2007). GGTase-I deficiency reduces tumor formation and improves survival in mice with K-RAS–induced lung cancer. Journal of Clinical Investigation. https://doi.org/10.1172/jci30868

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.